Monoclonal antibody MOC-31 reactivity as a marker for adenocarcinoma in cytologic preparations-Reference-Cited by-同舟云学术

Monoclonal antibody MOC-31 reactivity as a marker for adenocarcinoma in cytologic preparations

Published:2005-12-02 Issue:1 Volume:108 Page:56-59
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hecht Jonathan L.,Pinkus Jack L.,Pinkus Geraldine S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment;Willuda;Cancer Res.,1999

2. Frequent EpCam protein expression in human carcinomas;Went;Hum Pathol.,2004

3. HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma;Oates;Histopathology.,2000

4. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma;Ordonez;Hum Pathol.,1998

5. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma;Delahaye;J Pathol.,1991

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis of Body Fluids Using a Combined Approach of Cytomorphology in Routinely Stained Smears and Cell Blocks: A Boon for Primary Health Care in this Era of Molecular Medicine!;Journal of Public Health and Primary Care;2024-05

2. MOC31 Immunostaining in the Diagnosis of Metastatic Adenocarcinoma in Serous Fluid: Special Emphasis on Atypical Cytological Cases;Acta Cytologica;2021

3. Use of panel of markers in serous effusion to distinguish reactive mesothelial cells from adenocarcinoma;Journal of Cytology;2019

4. Utility of MOC-31 monoclonal antibody in differentiating metastatic adenocarcinoma cells and reactive mesothelial cells in effusion cytology;Indian Journal of Pathology and Microbiology;2018

5. Ascitic Fluid in Ovarian Carcinoma – From Pathophysiology to the Treatment;Ascites - Physiopathology, Treatment, Complications and Prognosis;2017-11-29